NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

RITRACT LIMITED (RTL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
VOLT RESOURCES LIMITED01/04/2016
MOZAMBI RESOURCES LTD16/12/201401/04/2016
MOZAMBI COAL LIMITED25/02/201116/12/2014
RTL CORPORATION LIMITED23/05/200825/02/2011
RITRACT LIMITED23/05/2008

Shareholder links

 

REGISTRY:

Advanced Share Registry Services
110 Stirling Hwy, Nedlands WA 6009
Tel : +61 8 9389 8033
Fax : +61 8 9262 3723
RegistryWebsite RegistryEmail

Company details

Address: Level 17 , 201 Miller Street , NORTH SYDNEY , NSW, AUSTRALIA, 2060
Tel:  02 8923 2512Fax: 02 8923 2525

Date first listed: 19/12/2003

Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Medical technology company offering products and technologies dor safety injection solutions

News & Events

Expand this box to read and print

name changed to RTL Corporation Limited

23/05/2008

securities reinstated to quotation

19/05/2008

the Company has now satisfied all pre-conditions to seeking reinstatement to trading of its securities on the Australian Securities Exchange and will be reinstated to quotation on Monday 19 May

16/05/2008

we understand that on or about this date the company consolidated its shares 1 for 2

17/04/2008

all resolutions were carried at the Company's General Meeting today

16/04/2008

capital of the company is being consolidated one share for every two held

16/04/2008

releases a placement prospectus

25/03/2008

releases half yearly accounts

29/02/2008

directors advise the market of certain material events that have allegedly resulted in the Company incurring substantial debts that the Directors were not previously aware of - as a result of these debts being brought to the attention of the Company, the Directors have limited options available to them to ensure that the Company remains a going concern

22/02/2008

a cash flow report for the quarter to 31 December 2007 shows a deficit at operating level of $70k and cash on hand of -$1k

31/01/2008

the company has recently begun discussions with another British company regarding the rights to the syringe technology - the company has several options for recapitalizing and moving forward, however these options are still in the process of being evaluated

25/01/2008

both resolutions at today's AGM were passed

30/11/2007

a cash flow report for the quarter to 30 September 2007 shows a deficit at operating level of $18k and cash on hand of $30k

01/11/2007

company provides notice of an Annual General Meeting to be held on Thursday 29 November 2007, at 11am (EST) at Level 12, 459 Collins Street, Melbourne, Victoria

30/10/2007

company releases its Preliminary Final Report

31/08/2007

company says its restructuring plan has been completed and overheads reduced to a minimum - the ASX trading halt on Ritract shares will stay in place until such time as the company has solid news to announce regarding three licensing deals

28/08/2007

a cash flow report for the quarter to 30 June 2007 shows a deficit at operating level of $146k and cash on hand of $48k

31/07/2007

after a restructuring, the company has only one employee, Mr Tom Davenport, who has been appointed Chief Executive Officer of the company (previously Head of Research and Development and Engineering) - the company is continuing discussions with companies who have expressed an interest in licensing the company's technology and/or have an interest in investing in the company

30/07/2007

MD Bill Nicklin and non-exec director Tony Fitzgerald resign

29/06/2007

securities suspended from quotation whilst a restructure is implemented

26/06/2007

shares reinstated to quotation

08/11/2006

company advises that pre market release testing found that a small percentage of products failed to operate correctly and under the rules of the QMS it is unable to release product - this had implications for the Company's ongoing funding requirements and in particular for the completion of its announced capital raising - it also prevented the completion and lodgement of Ritract's 2006 Annual Report - the Board has made the decision not to invest further funds into development of the Needlesleeve technology - the board expects the minor production issues to be overcome shortly

16/10/2006

securities suspended from quotation because of failure to lodge full year accounts for the period to 30 June 2006

02/10/2006

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Robert HemphillDirector
    Alex NeulingDirector16/04/2008
    Ashley PattisonDirector
    Guy RobertsonCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.